Navigation Links
Team Type 1 Takes First Place Finish in Race Across America
Date:6/26/2009

The OmniPod(R) Insulin Management System Lets Cyclists Focus on Winning in Record Setting Time

ANNAPOLIS, Md., June 26 /PRNewswire-FirstCall/ -- Today, Team Type 1 concluded the 28th Annual Race Across America in record-breaking time, finishing first-place in the 8-person team category division. In this 3,000 mile transcontinental cycling competition beginning in Oceanside, CA and ending in Annapolis, MD, Team Type 1 members were put to the ultimate athletic test enduring extreme desert temperatures, wind, the threat of thunderstorms, and rough terrain, all while having to constantly manage their diabetes.

"We are so proud that our team was able to break another Race Across America record and finish in first place," said Joe Eldridge, co-founder of Team Type 1. "Our team's mission is to show people with diabetes that they can accomplish anything if they work hard to control their disease. We hope our team's performance inspires other people to manage their diabetes so they can achieve their own goals."

Team Type 1 was created in 2004 by Phil Southerland and Joe Eldridge, a pair of avid cyclists with Type 1 diabetes. In 2006 and 2007, the pair captained Team Type 1 to back-to-back victories in the eight-person team division of the Race Across America (RAAM).

In this year's race, six of the eight team members were able to compete vigorously and control their glucose levels with the OmniPod(R) Insulin Management System: Jeff Bannink, Beaverton, Ore.; Alex Bowden, St. Charles, Mo.; Matt Brooks, Pickerington, Ohio; Lonny Knabe, Portland, Ore.; Bob Schrank, Gurnee, Ill.; Mark Suprenant, Milford, N.H.

"The revolutionary technology of the OmniPod let us focus on competing," commented Mark Suprenant, one of the winning TT1 RAAM cyclists. "OmniPod stood up to all the challenging conditions we faced from California to Maryland and enabled us to deliver our best performance ever."


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Free will takes flight: how our brains respond to an approaching menace
2. New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market
3. Sun Safety Outreach to Families Takes Flight at the Plano Hot Air Balloon Festival
4. Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts
5. Small Town Doctor Takes on Giants in Consumer Healthcare
6. Help is Available for Smokers Who Want to Quit as Minnesotas Smoke-Free Law Takes Effect Oct. 1
7. Growing Healthy with School Gardens Takes Root in Los Angeles Saturday
8. Randy Jackson Takes Aim at Diabetes
9. New Hampshire: 1st in the Nation Primary State Takes a Stand on E-Prescribing
10. Blood test takes step toward predicting Alzheimers risk, Stanford researchers find
11. Morrison Takes Aim at Underage Drinking in New Radio Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 1Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 2Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 4Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 5AMT Appoints New Chief Executive Officer 58224 1AMT Appoints New Chief Executive Officer 58224 2AMT Appoints New Chief Executive Officer 58224 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 1ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 2ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 4